The abnormal expression of NACC1 modulated the expression of ADAM9, subsequently activating the PI3K/AKT axis, enhancing the proliferation of AML cells, accelerating cell cycle progression, and inhibiting apoptosis. This evidence concerns the gene ADAM9 and acute myeloid leukemia.